Novartis Ag annual free cash flow
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Novartis Ag Free Cash Flow (FCF) History (NVS)
Novartis Ag reported $17.60B in free cash flow for fiscal 2025, an increase of 8.26% from the previous fiscal year, with a free cash flow margin of 32.27%.
View full Novartis Ag company overviewNovartis Ag free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | $17.60B | $1.34B | +8.26% | +32.27% |
| 2024 | 2024-12-31 | $16.25B | $2.85B | +21.31% | +32.30% |
| 2023 | 2023-12-31 | $13.40B | $78.0M | +0.59% | +29.49% |
| 2022 | 2022-12-31 | $13.32B | −$685.0M | −4.89% | +31.56% |
| 2021 | 2021-12-31 | $14.01B | $1.63B | +13.17% | +32.74% |
| 2020 | 2020-12-31 | $12.38B | $129.0M | +1.05% | +25.43% |
| 2019 | 2019-12-31 | $12.25B | −$772.0M | −5.93% | +25.78% |
| 2018 | 2018-12-31 | $13.02B | $1.72B | +15.24% | +29.04% |
| 2017 | 2018-01-01 | $11.30B | $1.68B | +17.51% | +26.65% |
| 2016 | 2016-12-31 | $9.61B | — | — | +19.81% |
Novartis Ag quarterly free cash flow
Q2.17
Q2.18
Q2.19
Q2.20
Q2.21
Q2.22
Q2.23
Q2.24
Q2.25
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2025 | 2025-06-30 | $6.33B | $2.52B | +66.18% | +45.06% |
| Q2 2024 | 2024-06-30 | $4.62B | $892.0M | +23.96% | +36.88% |
| Q2 2023 | 2023-06-30 | $3.35B | $519.0M | +18.33% | +29.30% |
| Q2 2022 | 2022-06-30 | $3.50B | −$187.0M | −5.07% | +27.37% |
| Q2 2021 | 2021-06-30 | $3.81B | $561.0M | +17.26% | +29.41% |
| Q2 2020 | 2020-06-30 | $3.72B | — | — | +32.81% |
| Q2 2019 | 2019-06-30 | $2.83B | — | — | +24.07% |
| Q2 2018 | 2018-06-30 | $3.69B | — | — | +32.44% |
| Q2 2017 | 2017-06-30 | $3.25B | — | — | +26.55% |
Novartis Ag free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from $12.38B to $17.60B, a compound annual growth rate of 7.29%. Novartis Ag's latest reported quarter, Q2 2025, generated $6.33B in free cash flow, an increase of 66.18% year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Novartis Ag filings at SEC.gov ↗